These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19999806)

  • 1. [Platelets haemostatic in patients with multiple myeloma].
    Kamińska J; Mantur M; Sawicka-Powierza J
    Pol Merkur Lekarski; 2009 Nov; 27(161):404-7. PubMed ID: 19999806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bruising and bleeding in infants and children--a practical approach.
    Khair K; Liesner R
    Br J Haematol; 2006 May; 133(3):221-31. PubMed ID: 16643424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The blood coagulation mechanism in multiple myeloma.
    Zangari M; Saghafifar F; Mehta P; Barlogie B; Fink L; Tricot G
    Semin Thromb Hemost; 2003 Jun; 29(3):275-82. PubMed ID: 12888931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bleeding and thrombosis in multiple myeloma and related plasma cell disorders.
    Coppola A; Tufano A; Di Capua M; Franchini M
    Semin Thromb Hemost; 2011 Nov; 37(8):929-45. PubMed ID: 22198858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemostatic abnormalities in multiple myeloma and related disorders.
    Glaspy JA
    Hematol Oncol Clin North Am; 1992 Dec; 6(6):1301-14. PubMed ID: 1452513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
    Jespersen J
    Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Deep vein thrombosis and pulmonary embolism in a patient with multiple myeloma treated with thalidomide and dexamethasone].
    Miyazawa Y; Irisawa H; Uchiumi H; Saitoh T; Handa H; Matsushima T; Tsukamoto N; Karasawa M; Murakami H; Nojima Y
    Rinsho Ketsueki; 2006 Jul; 47(7):656-60. PubMed ID: 16910577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dysfunction of platelets in uremia].
    Hryszko T; Małyszko J; Myśliwiec M
    Przegl Lek; 1999; 56(9):599-603. PubMed ID: 10695367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet function and survival in multiple myeloma.
    Gorski J; Luka K; Czestochowska E
    Haematologia (Budap); 1993; 25(2):131-5. PubMed ID: 8244200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis and management of bleeding and thrombosis in plasma cell dyscrasias.
    Eby C
    Br J Haematol; 2009 Apr; 145(2):151-63. PubMed ID: 19210509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anemia and hemostatic abnormalities associated with multiple myeloma].
    Aoki S; Shibata A
    Nihon Rinsho; 1995 Mar; 53(3):690-4. PubMed ID: 7699906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypercoagulability in patients with haematological neoplasia: no apparent initiation by tissue factor.
    Negaard HF; Iversen PO; Østenstad B; Iversen N; Holme PA; Sandset PM
    Thromb Haemost; 2008 Jun; 99(6):1040-8. PubMed ID: 18521506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Haemostatic aspects in clinical oncology].
    Langer F; Holstein K; Eifrig B; Bokemeyer C
    Hamostaseologie; 2008 Dec; 28(5):472-80. PubMed ID: 19132177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A new look at platelets and microparticles, including their role in haemostatic disorders and progression of neoplastic disease].
    Łuksza E; Mantur M
    Pol Merkur Lekarski; 2009 Dec; 27(162):491-5. PubMed ID: 20120715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis.
    Rajkumar SV; Mesa RA; Fonseca R; Schroeder G; Plevak MF; Dispenzieri A; Lacy MQ; Lust JA; Witzig TE; Gertz MA; Kyle RA; Russell SJ; Greipp PR
    Clin Cancer Res; 2002 Jul; 8(7):2210-6. PubMed ID: 12114422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anomalies of hemostasis in myeloma].
    Piguet H; Hayet M; Bastit P; Deshayes P
    Rev Rhum Mal Osteoartic; 1971; 38(6):439-43. PubMed ID: 5119608
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bleeding tendency in multiple myeloma--with special reference to platelet dysfunction (author's transl)].
    Mori K; Domae N; Sagawa K; Nishikawa H; Wano M; Takatsuki K; Yamagishi M; Yasunaga K; Uchino H
    Rinsho Ketsueki; 1979 Oct; 20(10):1331-9. PubMed ID: 541842
    [No Abstract]   [Full Text] [Related]  

  • 18. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S
    Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acquired platelet function disorders: pathogenesis, classification, frequency, diagnosis, clinical management].
    Scharf RE
    Hamostaseologie; 2008 Dec; 28(5):299-311. PubMed ID: 19132161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic criteria of multiple myeloma.
    Kyle RA
    Hematol Oncol Clin North Am; 1992 Apr; 6(2):347-58. PubMed ID: 1582977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.